Form 3 Filing for BioStem Technologies, Inc. - Ownership Change

This filing details changes in beneficial ownership for Brandon Poe, Chief Financial Officer of BioStem Technologies, Inc. (BSEM). Poe directly holds 45,734 shares of common stock. The filing also discloses various stock options and restricted stock units granted to Poe. Notably, stock options with an exercise price of $6.48 and 38,814 shares vest starting August 19, 2026, with further vesting over two years. Another set of stock options, totaling 117,401 shares at an exercise price of $5.50, vest starting February 11, 2027, also over two years. Restricted stock units totaling 84,69 shares vest quarterly over three years from September 15, 2024. Additional restricted stock units, amounting to 32,225 shares and 96,909 shares, have vesting schedules tied to August 19, 2026, and February 11, 2027, respectively, with remaining vesting over two years. Each restricted stock unit represents a contingent right to one share of common stock.